SEC Company Response from CNBX Pharmaceuticals (CNBX) — Jul 10, 2015
CNBX Pharmaceuticals Inc.
Date: July 10, 2015 · CIK: 0001343009 · Accession: 0001019687-15-002671
AI Filing Summary & Sentiment
File numbers found in text: 000-52403
Letter
Re: Cannabics Pharmaceuticals Inc. Form 10-K for the Fiscal Year Ended August 31, 2014 Filed December 15, 2014 File No. 000-52403
Dear Ms. Marlowe,
The Issuer is currently preparing its responses to your above-referenced Comments. Pursuant to our brief discussion this morning, the issuer is requesting an extension of its responses to these comments. Right now the Issuer is working on its quarterly filing at the same time as our responses and cannot do both effectively given the time constraints. We would expect to have them presented to you by end of next Friday, 17th of July.
Should you have any questions or comments, please do contact me at any time. Thank you for your understanding in this matter.
Sincerely yours,
/s/
David E. Price, Esq.
Show Raw Text
CORRESP
1
filename1.htm
#3 BETHESDA METRO CENTRE
SUITE 700
BETHESDA, MD 20814
---------
Tel (877) 424-2429
Cannabics.com
9th July, 2015
US Securities & Exchange Commission
Corporate Finance Division
Washington, DC 20549
Attn: Ms. Julie Marlowe
Re: Cannabics Pharmaceuticals Inc.
Form 10-K for the Fiscal Year Ended August
31, 2014
Filed December 15, 2014
File No. 000-52403
Dear Ms. Marlowe,
The Issuer is currently preparing its responses
to your above-referenced Comments. Pursuant to our brief discussion this morning, the issuer is requesting an extension of its
responses to these comments. Right now the Issuer is working on its quarterly filing at the same time as our responses and cannot
do both effectively given the time constraints. We would expect to have them presented to you by end of next Friday, 17th
of July.
Should you have any questions or comments, please
do contact me at any time. Thank you for your understanding in this matter.
Sincerely yours,
/s/
David E. Price, Esq.
David E. Price, Esq.